Labcorp Holdings (LH) Cash from Discontinued Operations (2022 - 2023)
Labcorp Holdings (LH) posted Cash from Discontinued Operations of 189900000.0 for Q2 2023, up 394.42% sequentially from 64500000.0 in Q1 2023.
Labcorp Holdings (LH) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends
Labcorp Holdings has reported Cash from Discontinued Operations for 2 years, with the latest figure at 189900000.0 in Q2 2023.
- Quarterly Cash from Discontinued Operations changed N/A year-over-year to 189900000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was 189900000.0 (changed N/A YoY) and the FY2023 annual result came in at 125400000.0, down 34.38% from the prior year.
- Cash from Discontinued Operations grew to 189900000.0 in Q2 2023 per LH's latest filing, from 64500000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 189900000.0 in Q2 2023 and troughed at 64500000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discont. Ops (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.99 Bn | 209.92 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.41 Bn | 136.06 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.27 Bn | 46.08 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.81 Bn | 38.00 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.53 Bn | 37.45 Bn | 1.44 Bn | - |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.67 Bn | 28.62 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn | - |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 189.90 Mn |
| Jun 30, 2023 | 189.90 Mn |
| Mar 31, 2023 | -64.50 Mn |
| Mar 31, 2023 | -64.50 Mn |
| Dec 31, 2022 | 46.40 Mn |
| Dec 31, 2022 | 46.40 Mn |
| Sep 30, 2022 | 120.80 Mn |
| Sep 30, 2022 | 120.80 Mn |